Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes

E Braunwald, A Maseri, PW Armstrong, RM Califf, WB Gibler, CW Hamm, Maarten Simoons, F van der Werf

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)22-30
Number of pages9
JournalEuropean Heart Journal
Volume19
Issue numbersupplement
Publication statusPublished - 1998

Research programs

  • EMC 05-01-43-06-03

Cite this